{"id":53587,"date":"2023-02-02T19:02:10","date_gmt":"2023-02-02T18:02:10","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\/"},"modified":"2023-02-02T19:02:10","modified_gmt":"2023-02-02T18:02:10","slug":"pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\/","title":{"rendered":"Pneuma Respiratory Announces a Novel Platform That Could Revolutionize Smoking Cessation Therapies and Reduced-Risk Nicotine Products"},"content":{"rendered":"<div>\n<p>BOONE, N.C.&#8211;(BUSINESS WIRE)&#8211;Pneuma Respiratory, a med-tech pharmaceutical company focused on the advancement of inhaled respiratory therapeutics, has created a new technology platform capable of delivering nonheated, water-based aerosols composed of droplets with diameters less than 1\/100,000<sup>th<\/sup> of an inch. Nonheated delivery of nicotine requires aerosols with extremely small droplet sizes. Pneuma\u2019s platform will, for the first time, provide a means to use nonheated aerosols for inhaled nicotine smoking cessation treatments and has the potential for a major impact on the reduced-risk nicotine consumer market.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230202005734\/en\/1704084\/19\/Pneuma_Video.mp4\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230202005734\/en\/1704084\/21\/Pneuma_Video.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20230202005734\/en\/1704073\/5\/image002.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230202005734\/en\/1704073\/21\/image002.jpg\"><\/a><\/p>\n<p>\nPneuma has a joint development program with a leading tobacco company aimed at creating nonheated nicotine delivery products. The heat in nicotine products creates chemical reactions that form toxins and carcinogens. With the elimination of heat, Pneuma is making great strides towards improving patient and consumer health.\n<\/p>\n<p>\nPneuma\u2019s Chief Technology Officer, Sid Clements, Ph.D., Fulbright Scholar, and Faculty Fellow at NASA\u2019s Electrostatics and Surface Physics Lab, stated, \u201cOur team at Pneuma has made a remarkable breakthrough in the delivery of aerosols with the extremely small droplets that are required for nonheated inhaled nicotine.\u201d\n<\/p>\n<p>\nPneuma will take its technology, in a fully digital platform, through clinical trials aimed at creating a therapeutic treatment for smoking cessation. Pneuma\u2019s clinical pathway for smoking cessation was affirmed by the FDA in a pre-IND meeting. Pneuma\u2019s digital platform is designed to precisely deliver nicotine to satisfy cravings and dynamically step down the amount over time. Sensors track and report feedback to the user about their nicotine consumption and trends via an app. Onboard authentication via fingerprint scanner eliminates the ability for misuse by youth or anyone not authorized to use the device.\n<\/p>\n<p>\nPneuma\u2019s Chairman Jay Morgan, former Chief Research Officer at Merck Consumer Health, remarked, \u201cPneuma has laid the groundwork for products that can go a long way toward helping patients stop smoking.\u201d\n<\/p>\n<p>\nAbout Pneuma Respiratory\n<\/p>\n<p>\nFounded in 2015, Pneuma Respiratory is a med-tech pharmaceutical company with 60 employees that have expertise in drug formulation development, aerosol physics and handheld digital device design. Pneuma is based in Boone, North Carolina, with operations in Shenzhen, China. Combining its proprietary aerosol generation technology with the precision of digital systems, Pneuma\u2019s platform technology is driving multiple therapeutic and nontherapeutic programs. In addition to smoking cessation and reduced-risk nicotine, Pneuma\u2019s programs target COPD and other lung conditions. Pneuma\u2019s high volume manufacturing partner is Foxconn, the leader in manufacturing handheld digital devices. Pneuma has 28 issued patents and 88 pending applications covering its technology and products. For more information, visit landing.pneumarespiratory.com.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nEmily Rios<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;a&#x69;l&#x74;&#111;&#x3a;&#101;&#x72;&#105;o&#x73;&#64;&#x74;&#114;&#x65;&#118;&#x65;&#108;&#x69;&#110;o&#x6b;e&#x6c;&#108;&#x65;&#114;&#x2e;&#99;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">e&#114;&#x69;&#x6f;&#x73;&#64;&#116;&#x72;&#x65;&#x76;e&#108;&#x69;&#x6e;&#x6f;k&#101;&#x6c;&#x6c;&#x65;r&#46;&#x63;&#x6f;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOONE, N.C.&#8211;(BUSINESS WIRE)&#8211;Pneuma Respiratory, a med-tech pharmaceutical company focused on the advancement of inhaled respiratory therapeutics, has created a new technology platform capable of delivering nonheated, water-based aerosols composed of droplets with diameters less than 1\/100,000th of an inch. Nonheated delivery of nicotine requires aerosols with extremely small droplet sizes. Pneuma\u2019s platform will, for the &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53587","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pneuma Respiratory Announces a Novel Platform That Could Revolutionize Smoking Cessation Therapies and Reduced-Risk Nicotine Products - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pneuma Respiratory Announces a Novel Platform That Could Revolutionize Smoking Cessation Therapies and Reduced-Risk Nicotine Products - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BOONE, N.C.&#8211;(BUSINESS WIRE)&#8211;Pneuma Respiratory, a med-tech pharmaceutical company focused on the advancement of inhaled respiratory therapeutics, has created a new technology platform capable of delivering nonheated, water-based aerosols composed of droplets with diameters less than 1\/100,000th of an inch. Nonheated delivery of nicotine requires aerosols with extremely small droplet sizes. Pneuma\u2019s platform will, for the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-02T18:02:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230202005734\/en\/1704084\/21\/Pneuma_Video.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Pneuma Respiratory Announces a Novel Platform That Could Revolutionize Smoking Cessation Therapies and Reduced-Risk Nicotine Products\",\"datePublished\":\"2023-02-02T18:02:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\\\/\"},\"wordCount\":449,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230202005734\\\/en\\\/1704084\\\/21\\\/Pneuma_Video.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\\\/\",\"name\":\"Pneuma Respiratory Announces a Novel Platform That Could Revolutionize Smoking Cessation Therapies and Reduced-Risk Nicotine Products - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230202005734\\\/en\\\/1704084\\\/21\\\/Pneuma_Video.jpg\",\"datePublished\":\"2023-02-02T18:02:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230202005734\\\/en\\\/1704084\\\/21\\\/Pneuma_Video.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230202005734\\\/en\\\/1704084\\\/21\\\/Pneuma_Video.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pneuma Respiratory Announces a Novel Platform That Could Revolutionize Smoking Cessation Therapies and Reduced-Risk Nicotine Products\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pneuma Respiratory Announces a Novel Platform That Could Revolutionize Smoking Cessation Therapies and Reduced-Risk Nicotine Products - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\/","og_locale":"en_US","og_type":"article","og_title":"Pneuma Respiratory Announces a Novel Platform That Could Revolutionize Smoking Cessation Therapies and Reduced-Risk Nicotine Products - Pharma Trend","og_description":"BOONE, N.C.&#8211;(BUSINESS WIRE)&#8211;Pneuma Respiratory, a med-tech pharmaceutical company focused on the advancement of inhaled respiratory therapeutics, has created a new technology platform capable of delivering nonheated, water-based aerosols composed of droplets with diameters less than 1\/100,000th of an inch. Nonheated delivery of nicotine requires aerosols with extremely small droplet sizes. Pneuma\u2019s platform will, for the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-02T18:02:10+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230202005734\/en\/1704084\/21\/Pneuma_Video.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Pneuma Respiratory Announces a Novel Platform That Could Revolutionize Smoking Cessation Therapies and Reduced-Risk Nicotine Products","datePublished":"2023-02-02T18:02:10+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\/"},"wordCount":449,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230202005734\/en\/1704084\/21\/Pneuma_Video.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\/","url":"https:\/\/pharma-trend.com\/en\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\/","name":"Pneuma Respiratory Announces a Novel Platform That Could Revolutionize Smoking Cessation Therapies and Reduced-Risk Nicotine Products - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230202005734\/en\/1704084\/21\/Pneuma_Video.jpg","datePublished":"2023-02-02T18:02:10+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230202005734\/en\/1704084\/21\/Pneuma_Video.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230202005734\/en\/1704084\/21\/Pneuma_Video.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/pneuma-respiratory-announces-a-novel-platform-that-could-revolutionize-smoking-cessation-therapies-and-reduced-risk-nicotine-products\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Pneuma Respiratory Announces a Novel Platform That Could Revolutionize Smoking Cessation Therapies and Reduced-Risk Nicotine Products"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53587","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53587"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53587\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53587"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53587"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53587"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}